Seeking Alpha

Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review

PDUFA date set for February 7, 2025 If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as ...
Morningstar

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...
Business Insider

Albertsons & Bicycle Health Collaborate to Tackle Nation’s #1 Health Crisis - Opioid use Disorder - by Making Prescriptions Sublocade Injections Available at Over 700 Pharmacies

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s largest provider of telemedicine treatment for opioid use disorder, announced today that it will make prescriptions for ...